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Abstract
In 2004 the Brazilian National Cancer Institute (INCA) established breast cancer screening 
guidelines for women in Brazil: annual clinical breast exam for women age 40–49 and biennial 
mammogram for women age 50–69. Healthcare provider’s adherence to these guidelines is 
currently unknown. The objective of this study is to describe the perceptions and practices related 
to breast cancer screening among physicians, nurses, and health unit coordinators working in the 
network of primary healthcare units (HCUs) in Brazil.
In 2011, 1600 primary HCUs were randomly sampled from all regions in Brazil. At each HCU the 
coordinator and one health professional were asked to participate in a telephone survey to gathered 
information on their knowledge, attitudes, and practices related to breast cancer screening. 
Participation rates for coordinators, physicians, and nurses were 78%, 34%, and 65% respectively.
Health unit coordinators identified numerous barriers that prevent patients from receiving 
appropriate screening, many (44%) were unaware of INCA cancer screening guidelines. Despite a 
high perceived impact of INCA guidelines, a majority of physicians and nurses did not follow 
them. Most physicians and nurses recommended mammograms on an annual basis (~75%) and 
50.9% of nurses and 25.1% of physicians initiated routine breast cancer screening in women under 
age 40.
Physicians and nurses in Brazil screen at younger ages and more frequently than recommended by 
INCA guidelines. Given that primary HCUs are the source of health care for many women, 
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interventions that educate healthcare providers on the appropriate ages and intervals for breast 
cancer screening may prove useful.
Keywords
Cancer screening; Breast cancer; Mammography; Clinical breast exam; Breast cancer screening; 
Brazil; Physician; Nurse; Breast
1. Introduction
Breast cancer is the most common cancer in women worldwide and 70% of deaths from 
breast cancer occur in low and middle-income countries (Mathers et al., 2008). The 
incidence of breast cancer in Latin American countries is generally lower compared with 
high-income countries (Curado et al., 2007), whereas the mortality rate is higher (Pisani et 
al., 2002). In 2012, approximately 52,000 new cases of breast cancer were reported in Brazil 
(Silva et al., 2011), and the mortality rate has increased from 9.2 per 100,000 women in 
1980 to 11.3 per 100,000 women in 2009 (Freitas-Junior et al., 2012). The highest rates of 
breast cancer are noted in southern Brazil (INCA, 2012).
All Brazilian citizens have the right to procure free medical assistance from the public 
healthcare system called the Unified Health System (SUS). Cancer care services are 
provided within the network of primary healthcare units (HCUs) known as the Family 
Health Program (M.d. Saúde Brasil and d.N.d. Câncer, 2009). These services have been 
expanded through the public system into state or regional referral centers that are 
responsible for providing diagnosis and treatment (Política nacional de atenção oncológica, 
2010). A multidisciplinary team including physicians, nurses and community health workers 
play a crucial role in conducting cancer prevention and control activities (Política nacional 
de atenção oncológica, 2010).
Screening guidelines established by Brazilian National Cancer Institute (INCA) recommend 
breast cancer screening initiation at age 40 for asymptomatic women at average risk, and 35 
for high-risk women (Precoce, 2004). An annual clinical breast exam (CBE) is 
recommended for women aged 40 to 49 years and screening mammography every two years 
for women aged 50 to 69 years (Lima-Costa and Matos, 2007). Health care provider’s 
adherence to breast cancer screening guidelines is unknown. Literature has reported that 
only 35% of Brazilian women aged 50 to 69 years receive appropriate breast cancer 
screening, and 50% of women older than 50 years have had at least one mammogram (Lima-
Costa and Matos, 2007), but few receive regular screening (Marinho et al., 2008). In 
addition, 45% of screening mammograms in Brazil were undertaken in women younger than 
50 years (Simon et al., 2009; Marchi and Gurgel, 2010). Few users of public health services 
in Brazil are aware or receive information about breast cancer screening methods and 
practices (i.e., mammography) (Gonçalves-Silva et al., 2010).
Physicians and nurses are a direct source of health information for the population, the 
information they provide must be accurate and the recommended screening procedures 
appropriate (Gonçalves-Silva et al., 2010). Since the most common reported barrier to 
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mammography is the absence of referral by providers working in health care settings, it is 
important to determine which factors may influence provider’s adherence to breast cancer 
screening guidelines in Brazil. The identification of these factors could be useful to develop 
strategies to improve early diagnosis and treatment of breast cancer.
The objective of our study is to describe the demographic characteristics, perceptions and 
practices related to adherence of breast cancer screening guidelines among physicians and 
nurses working in the network of primary HCUs in Brazil, and determine which factors may 
influence their adherence to these screening guidelines.
2. Methods
As part of the Guide for Useful Interventions for Physical Activity in Brazil and Latin 
America (GUIA) project, a telephone survey was administered to health unit coordinators 
and health professionals in Brazil. Two surveys were developed (one for unit coordinators, 
one of health professionals) as part of the GUIA project (www.projectguia.org), focusing on 
gathering information on individual’s knowledge, attitudes, and practices related to physical 
activity, nutrition, and cancer. Of the 42,486 HCUs in Brazil, 1600 primary HCUs were 
randomly sampled for inclusion in the GUIA project. At each selected HCU, phone 
interviews were conducted with the health unit coordinator and one health professional 
(physician, nurse, or community health worker). The original sample included 1600 health 
unit coordinators, 534 physicians, 533 nurses, and 533 community health workers. There 
were no exclusion criteria and participation was voluntary. In total 1251 coordinators (78%), 
347 nurses (65%), 182 physicians (34%), and 273 community health workers (51%) agreed 
to participate. The present analysis relied only on data from coordinators, physicians, and 
nurses, as they are responsible for breast cancer screening activities in Brazil, and 
community health workers were not asked breast cancer screening questions. More details 
about the design and sampling methods can be found elsewhere (Perin et al., 2015; Stormo 
et al., 2014). This study was reviewed and approved by the Research Ethics Committee of 
the Federal University of Pelotas, and the institutional review boards of Washington 
University in St. Louis and the U.S. Centers for Disease Control and Prevention.
The survey for health unit coordinators contained questions related to the coordinator’s 
knowledge of breast cancer screening, the health units’ capacity to provide breast cancer 
screening services, and barriers patients faced in receiving appropriate screening services. 
The survey for physicians and nurses focused on the perceived effectiveness of breast cancer 
screening measures, their breast cancer screening practices, and their adherence to INCA’s 
breast cancer screening guidelines. The six questions included in this study from the 
coordinator survey, and the nine questions included in this study from the physician and 
nurse survey can be observed in Table A.1 and Table A.2 respectively. Information on survey 
development, implementation, and pilot testing has been previously described (Perin et al., 
2015; Stormo et al., 2014).
2.1. Statistical analyses
For the coordinator survey we summarized responses pertaining to breast cancer screening 
practices and barriers that were reported by health unit coordinators. For the health 
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professional survey, we conducted bivariate analyses to examine differences between nurses 
and physicians regarding gender, age, race, region, patients seen per week, hours worked per 
week, years since graduation, and breast cancer related perceptions, practices and adherence 
to INCA screening guidelines. We used Pearson chi-square to test statistical differences (α 
= 0.05).
To determine if breast cancer knowledge or attitudes impacted health professional’s breast 
cancer screening practices, we limited the analysis to individuals who self-reported that they 
partook in breast cancer screening and compared individuals knowledge and attitudes with 
their screening practices using Pearson chi-square to test for statistical differences (α = 
0.05).
3. Results
3.1. Implementation and barriers to breast cancer screening at HCUs — coordinator survey
In the coordinator survey, 45% of health unit coordinators reported that they were unaware 
of INCA recommendations for cancer screening. Among health unit coordinators that were 
aware of INCA screening guidelines, 98% reported that their unit followed the INCA 
recommendations for the early detection of breast cancer. Coordinators identified a number 
of barriers to breast cancer screening including; difficulty in performing mammograms 
(47.8%), difficulties in making or re-scheduling appointments (47.4%), long wait times on 
exam days (46.0%), difficulty in marking X-rays (37.7%), and difficulty scheduling 
appointments to discuss mammography results (29.6%; Table 1).
3.2. Provider characteristics and attitudes, perceptions, and practice of breast cancer 
screening
When compared to nurses, physicians were more likely to be male, older (mean age 40.5 vs. 
32.6), out of school longer, work fewer hours and see more patients per week. Reflective of 
the general population distribution, most physicians and nurses were practicing in the 
southeast or northeast of Brazil (Table 2).
The majority of physicians and nurses perceived the INCA breast cancer screening 
recommendations as very influential in their health care unit (62.7%). More often than 
physicians, nurses perceived the clinical breast exam (p = 0.02), self-breast exam (p < 
0.001), and mammograms for women between 40 and 49 years old (p < 0.001) as very 
effective at reducing breast cancer mortality. Film mammography for women 50 years and 
older was perceived as very effective by 98% of physicians and 95% of nurses. Doctors felt 
more prepared to talk about breast cancer with patients when compared to nurses (p = 
0.0043; Table 3).
Nurses were more likely to report that they initiated clinical breast exams or mammograms 
in women under 40 years old when compared to physicians (p < 0.0001), with 50.9% of 
nurses and 25.1% of physicians reporting that they initiated routine breast cancer screening 
in women below age 40. A majority of physicians and nurses recommended annual clinical 
breast exams and annual mammograms for their patients (Table 3). No demographic or 
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regional characteristics were found to be associated with screening compliance among 
physicians or nurses.
3.3. Comparing breast cancer screening attitudes and perceptions to screening practices 
and intentions
When comparing breast cancer knowledge and attitudes to physicians self-reported breast 
cancer screening practices, physicians who believed that mammograms in women age 40–49 
were very effective at reducing breast cancer mortality were more likely to report initiating 
breast cancer screening before age 40 with their patients. Although not significant at the p = 
0.05 level, physicians who self-reported that they were prepared to talk to patients about 
breast cancer were more likely to report that they began breast cancer screening in women 
who were > 40 years old (Table 4). When comparing breast cancer knowledge and attitudes 
of nurses with their self-reported breast cancer screening practices, no significant differences 
arose at the p = 0.05 level (Table 5).
4. Discussion
In Brazil, the vast majority of physicians and nurses of SUS are initiating breast cancer 
screening with their patients, which is to be expected as policies are in place to ensure that 
all women can access these services. Although most physicians and nurses of SUS 
considered the INCA breast cancer screening guidelines as very influential at their primary 
HCU, many health professionals did not appear to be following the guidelines and were over 
screening the eligible population. The results from this study suggest that health 
professionals in the Brazilian SUS screen patients more frequently and initiate screening at 
younger ages than recommended by INCA guidelines, which is likely negatively impacting 
the cost-effectiveness of the breast cancer screening program in Brazil. Given the limited 
time of physicians and nurses of SUS, stricter adherence to INCA guidelines would decrease 
their screening load and improve their capacity to screen age-eligible women in the 
population.
Despite the INCA recommendation issued in 2004 to give mammograms biennially to 
women age 50–69, 72.3% of physicians and 73.5% of nurses in this study recommend 
mammograms to their patients on an annual basis. It is important to note that biennial 
screening is not unique to the INCA screening guidelines, and the World Health 
Organization (WHO), the International Agency for Research on Cancer (IARC), and the US 
Preventive Services Task Force (USPSTF) all currently recommend biennial breast cancer 
screening via mammography for women aged 50–69 at a minimum (Mandelblatt et al., 
2009; Lauby-Secretan et al., 2015; World Health Organization, 2014; US Preventive 
Services Task Force, 2016). For women 40–49, WHO, IARC, and the USPSTF recommend 
biennial screening if the women value the potential benefit of mammography more than the 
harms after a discussion with their healthcare provider (Mandelblatt et al., 2009; Lauby-
Secretan et al., 2015; World Health Organization, 2014; US Preventive Services Task Force, 
2016).
Unfortunately, while this study recorded the age at which physicians and nurses initiated 
breast cancer screening, it did not differentiate between the age of initiation for clinical 
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breast exams vs. mammography. Despite this, while INCA recommends annual clinical 
breast exams for women age 40–49, 50.9% of nurses and 25.1% of physicians in our study 
began breast cancer screening in women before age 40. While previous work in low and 
middle income countries has shown that clinical breast exams do not lower breast cancer 
mortality, screened women are significantly more likely to present with smaller tumors and 
at earlier stages than women receiving education alone (Mittra et al., 2010). These results 
suggest that clinical breast exams could potentially lower breast cancer mortality among 
screened women when longer follow-up information is available. Potentially due to an 
overestimation of the impact that mammograms have among women age 40–49, physicians 
who believed that mammograms in women age 40–49 were very effective at reducing breast 
cancer mortality were more likely to report initiating breast cancer screening before age 40.
It is likely that physicians and nurses of SUS are initiating screening younger and more 
frequently than guidelines suggest because they believe it to be beneficial to their patients. 
However, at the population level, this is not the case. Previous modeling studies have found 
that biennial screening of women aged 50–69 with mammography reduces breast cancer 
related mortality by 16.5% (Mandelblatt et al., 2009). When the age limit was lowered to 40, 
only an additional 3% of breast cancer related deaths were prevented (Mandelblatt et al., 
2009). Given that a majority of breast cancer tumors are slow growing, increasing screening 
from biennially to annually added negligible survival benefit (Mandelblatt et al., 2009).
The results from this study suggest that SUS health professionals are over screening 
Brazilian women, potentially due to inaccurate assumptions on the efficacy of screening 
women younger and more frequently than INCA guidelines suggest. One possible 
contributing factor for over screening young women by SUS physicians and nurses is the 
lower SES of SUS patients (Gragnolati et al., 2013). Low SES women who are young may 
work long and odds hours, thus creating barriers for scheduling screening. Since these 
women have greater utilization of SUS primary care services due to prenatal care and highly 
prevalent pediatric issues, physicians and nurse may take advantage of these opportunities to 
overcompensate scheduling barriers with aggressive scheduling of screening. Educating 
health professionals on the efficacy of breast cancer screening, appropriate screening 
intervals, and the ideal age of screening initiation, may help reduce the number of 
mammograms provided by primary HCUs, allowing them to further expand their coverage 
of the age-eligible population.
When implementing a population-based cancer screening program, it is essential to 
eliminate barriers at every step of the screening process to maximize program participation 
and program effectiveness. When inquiring about the barriers that women face when 
undergoing breast cancer screening at their primary HCU, 76% of health unit coordinators 
listed at least one barrier that women face in receiving adequate breast cancer screening, and 
39% of health unit coordinators listing two or more barriers. Many of the barriers reported 
by health unit coordinators (long wait times on exam day, difficulty making appointments, 
etc.) would likely be exacerbated by over screening, and it is possible that stricter adherence 
to INCA screening guidelines could alleviate many of these barriers. In addition, knowledge 
of these barriers is important for both improving coverage and the follow-up of abnormal 
results.
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Given the minimal benefit of providing mammograms to women age 40–49 (Mandelblatt et 
al., 2009) when such a large portion (65%) of women age 50–69 do not receive adequate 
screening, more focus could be placed on screening older (rather than younger) women. 
Brazil doesn’t have an organized national or regional breast cancer screening but exams are 
performed in an opportunistic manner (Ministério da Saúde, 2004). The lack of a systematic 
method to invite and monitor women who are screened may contribute to this discrepancy 
and also lead to over screening, although our survey wasn’t designed to assess these issues. 
With an expansion of coverage, a focus on providing mammograms to the target age range, 
and screening biennially, an organized breast cancer screening program in Brazil could be 
more cost effective and would prevent more breast cancer related deaths than the current 
approach (Duffy et al., 2002).
4.1. Study limitations
This study has a few limitations. All data gathered for this study were collected by self-
report, and it is possible that recall or social desirability bias impacted the results. The 
participation rate among physicians was low and results could potentially change given 
higher participation rates or sample sizes. This is, however, the first study to gather 
information on individual’s knowledge, attitudes, and practices related to breast cancer 
screening in Brazil. While the 1251 primary HCUs that agreed to participate are likely 
representative of Brazil’s primary HCU network, only 75% of the population utilize SUS 
and it is possible that these findings are not representative of providers who practice in the 
private setting (Cecilio et al., 2015).
5. Conclusions
In conclusion, stricter adherence to screening guidelines would allow for improved coverage 
of the population, and work to reduce the numerous barriers to breast cancer screening 
reported by primary HCU coordinators that are likely exacerbated by over screening. 
Educating health care providers on the effectiveness of mammograms at various age 
intervals could be conducted to improve their adherence to INCA guidelines. Although 
initiating mammography at younger ages and screening on an annual basis can prevent 
additional breast cancer deaths, given the large percentage of the population who are not 
covered by the minimum screening standards, stricter adherence to INCA screening 
recommendations could expand coverage and save more lives than the current approach.
Appendix A
Table A.1
Survey questions on breast cancer-related attitudes, knowledge, and barriers administered to 
coordinators; GUIA, 2011, Brazil.
Item and response categories
1 Do you know INCA recommendations for cancer screening?a
– Yes
– No
2 Does your unit follow the INCA recommendations for the early detection of breast cancer?a
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Item and response categories
– Yes
– No
3 Does your unit carry out outreach or tracking activities for breast cancer screening?a
– Yes
– No
4 Does your unit accompany women who have not returned to discuss the results of mammography with a 
health professional?a
– Yes
– No
5 How does your unit follow patients who did not return to discuss the results of their mammogram?a
– Telephone (yes/no)
– Home visits (yes/no)
– Other (yes/no)
6 Patients may encounter several barriers that prevent them from receiving comprehensive early detection 
of cancer. For each possible barrier listed, respond if it is not a barrier, is sometimes a barrier, or is 
definitely a barrier.
– Difficulties to receive radiography
– Difficulties to receive a mammogram
– Difficulties in making or rescheduling an appointment
– Long wait time on exam day
– Difficulty scheduling to discuss mammogram results
aQuestions included a “Do not know” category.
Table A.2
Survey questions on breast cancer-related attitudes, knowledge, and practices administered 
to physicians and nurses working in Brazil’s network of primary care units; GUIA, 2011, 
Brazil.
Item and response categories
1 In 2004, INCA released a consensus on the recommended frequency of clinical breast exams and 
mammograms for women with no symptoms, at medium, or high risk of developing breast cancer. At the 
health unit where you work would you say this guideline is…
– Very influential
– Not very influential
– Not influential
2 How effective do you believe breast self-examination is in reducing breast cancer mortality?
– Very effective
– Slightly effective
– Not effective
– Effectiveness not known
3 How effective do you believe clinical breast exams are in reducing breast cancer mortality?
– Very effective
– Slightly effective
– Not effective
– Effectiveness not known
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Item and response categories
4 How effective do you believe mammograms for women aged 40–49 is in reducing breast cancer 
mortality?
– Very effective
– Slightly effective
– Not effective
– Effectiveness not known
5 How effective do you believe mammograms for women over age 50 is in reducing breast cancer 
mortality?
– Very effective
– Slightly effective
– Not effective
– Effectiveness not known
6 At what age do you start routine breast cancer screening?
< 40 years
40–45 years
45–49 years
≥50 years
7 How often do you request that your patients receive a clinical breast examination?
Every _____ years
8 How often do you request that your patients receive a mammogram?
Every _____ years
9 How prepared do you feel to talk to patients about breast cancer?
Not prepared
A little bit prepared
Pretty prepared
All questions in the survey included a “Do not know” category. For question 7 and 8 participants were instructed to provide 
numeric answer in years.
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Table 1
Knowledge, implementation, and barriers to breast cancer screening reported by health unit coordinators (n = 
1251); GUIA, Brazil, 2011.a
Breast cancer screening, n (%)
Do you know INCA recommendations for cancer screening?
 Yes 651 (55.1)
 No 531 (44.9)
If yes, does your unit follow INCA recommendations for cancer screening?
 Yes 596 (93.1)
 No 44 (6.9)
If yes, does your unit follow the INCA recommendations for the early detection of breast cancer?
 Yes 586 (98.3)
 No 10 (1.7)
Does your unit carry out outreach or tracking activities for breast cancer?
 Yes 581 (97.7)
 No 14 (2.3)
Does your unit follow-up with women who have not returned to discuss the results of mammography with a health professional?
 Yes 963 (78.9)
 No 258 (21.1)
Barriers to breast cancer screening, n (%)
Difficulties in making X-rays
 Not a barrier 637 (52.2)
 Sometimes a barrier 230 (18.8)
 Definitely a barrier 354 (29.0)
Difficulty in marking X-rays
 Not a barrier 765 (62.3)
 Sometimes a barrier 236 (19.2)
 Definitely a barrier 227 (18.5)
Difficulty in making or re-scheduling an appointment
 Not a barrier 644 (52.6)
 Sometimes a barrier 256 (20.9)
 Definitely a barrier 324 (26.5)
Long wait time on exam day
 Not a barrier 629 (54.0)
 Sometimes a barrier 241 (20.7)
 Definitely a barrier 294 (25.3)
Difficulty scheduling to discuss mammogram results
 Not a barrier 851 (70.4)
 Sometimes a barrier 166 (13.7)
 Definitely a barrier 192 (15.9)
a
Missing, refused, and don’t know responses were not included in the table and subsequent percentage calculations.
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Table 2
Physicians’ and nurses’ demographic and professional characteristics (n = 529); GUIA, Brazil, 2011.
Item Physicians (n = 182) Nurses (n = 347) χ2 p-value
Gender, %
 Male 56.6 15.3 < 0.0001
 Female 43.4 84.7
Age (year)
 Mean (SD) 40.5 (12.8) 32.6 (8.5) < 0.0001a
Race/ethnicity, %
 White 67.6 62.0 0.6362
 Black 5.5 6.9
 Asian 2.8 3.5
 Mixed 24.2 27.7
Region, %
 North 6.0 2.5 0.0173
 Northeast 26.9 37.2
 Central-West 11.5 6.3
 Southeast 35.7 32.5
 South 19.8 21.6
Years since graduation
 ≤5 36.7 56.4 < 0.0001
 6–15 30.0 34.0
 > 15 33.3 9.6
Hours worked per week
 < 40 h 45.6 22.8 < 0.0001
 ≥40 h 54.4 77.2
Patients seen per week
 0–50 18.5 42.6 < 0.0001
 51–100 25.3 40.4
 > 100 56.2 17.0
a
Two sample T-test.
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Table 3
Breast cancer related attitudes, perceptions, and practices of health professionals working in health care units 
(n = 529); GUAI, Brazil, 2011.
Item, n (%) Physicians (n = 
182)
Nurses (n = 347) χ2 p-value
Attitudes and perceptions related to breast cancer screening
How prepared do you feel to talk to patients about breast cancer?
 Pretty much prepared 104 (57.1) 153 (44.1) 0.0043
 A little or not prepared 78 (42.9) 194 (55.9)
How effective is breast self-examination at reducing breast cancer mortality?
 Very effective 96 (54.6) 256 (75.3) < 0.0001
 Slightly or not effective 80 (45.4) 84 (24.7)
How effective is a clinical breast exam in reducing breast cancer mortality? 116 (65.9) 256 (75.3) 0.0242
 Very effective 60 (34.1) 84 (24.7)
 Slightly or not effective
How effective are mammograms among women age 40–49 at reducing breast cancer 
mortality?
 Very effective 156 (88.6) 329 (96.2)
 Slightly or not effective 20 (11.4) 13 (3.8) 0.0008
How effective are mammograms among women age > 50 at reducing breast cancer 
mortality?
 Very effective 171 (98.3) 320 (94.7) 0.0516
 Slightly effective 3 (1.7) 18 (5.3)
At the health facility where you work, would you say that INCA breast cancer 
screening guidelines are:
 Very influential 96 (62.7) 190 (62.7) 0.9935
 Not very or not influential 57 (37.3) 113 (37.3)
Practice and intentions
At what age do you start routine breast cancer screening in your patients?
 < 40 44 (25.1) 174 (50.9) < 0.0001
 40–45 75 (42.9) 123 (36.0)
 45–50 15 (8.6) 14 (4.1)
 > 50 15 (8.6) 11 (3.2)
I do not screen for breast cancer 26 (14.9) 20 (5.9)
How often do you request that your patients receive a clinical breast examination?a
 Every year 85 (57.4) 170 (53.0) 0.4073
 Every two years 4 (2.7) 5 (1.6)
 Other 59 (39.9) 146 (45.5)
How often do you request that your patients receive a mammogram?a
 Every year 107 (72.3) 236 (73.5) < 0.0001
 Every two years 36 (24.3) 35 (10.9)
 Other 5 (3.4) 50 (15.6)
aApplies only to individuals who screen for breast cancer.
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